Express Pharma

P&G announces Q3 results

The company has delivered total sales of Rs 262 crores for the quarter ended 31st March, 2022 vs Rs 214 crores, up by 23 per cent vs year ago

0 219

Procter & Gamble (P&G) Health has announced its financial results for the quarter ended 31st March, 2022. The company has delivered total sales of Rs 262 crores for the quarter ended 31st March, 2022 vs Rs 214 crores, up by 23 per cent vs year ago, a company statement informed.

The Profit After Tax (PAT) was Rs 51.2 crores, up by 224 per cent vs year ago. Increase in PAT is driven by higher sales and lower marketing and depreciation charge vs same period last year.  Sales for the nine-month period ending 31st March, 2022 were Rs 803 crores, vs Rs 710 crores, up 13 per cent vs a year ago. PAT for nine-month period is Rs 151 crores vs Rs 143 crores a year ago, despite high inflati